DK0760366T3 - Prostaglandinderivater - Google Patents
ProstaglandinderivaterInfo
- Publication number
- DK0760366T3 DK0760366T3 DK96306174T DK96306174T DK0760366T3 DK 0760366 T3 DK0760366 T3 DK 0760366T3 DK 96306174 T DK96306174 T DK 96306174T DK 96306174 T DK96306174 T DK 96306174T DK 0760366 T3 DK0760366 T3 DK 0760366T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- blood flow
- prostaglandin
- decubitus
- chem
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
- 230000017531 blood circulation Effects 0.000 abstract 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 208000004210 Pressure Ulcer Diseases 0.000 abstract 1
- -1 Prostaglandin E1 ester Chemical class 0.000 abstract 1
- 206010040943 Skin Ulcer Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229960000711 alprostadil Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 231100000019 skin ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23898495 | 1995-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0760366T3 true DK0760366T3 (da) | 2000-04-17 |
Family
ID=17038205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96306174T DK0760366T3 (da) | 1995-08-25 | 1996-08-23 | Prostaglandinderivater |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5698590A (de) |
| EP (1) | EP0760366B1 (de) |
| KR (1) | KR100227541B1 (de) |
| AT (1) | ATE189214T1 (de) |
| DE (1) | DE69606364T2 (de) |
| DK (1) | DK0760366T3 (de) |
| ES (1) | ES2142547T3 (de) |
| GR (1) | GR3033195T3 (de) |
| PT (1) | PT760366E (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007074604A1 (ja) * | 2005-12-26 | 2007-07-05 | Ltt Bio-Pharma Co., Ltd. | 水溶性非ペプチド性低分子薬物含有ナノ粒子 |
| WO2008101173A2 (en) * | 2007-02-16 | 2008-08-21 | Cornell University | Biodegradable compositions and materials |
| WO2008139804A1 (ja) * | 2007-05-14 | 2008-11-20 | Ltt Bio-Pharma Co., Ltd. | 徐放性の陰荷電基を持つ低分子薬物含有ナノ粒子 |
| AU2009246330B2 (en) * | 2008-05-14 | 2015-04-02 | Peter Thomas Roth Labs, Llc | Prostaglandin based compositions and method of use thereof |
| US8569279B2 (en) | 2009-05-27 | 2013-10-29 | Sucampo Ag | Method for modulating claudin mediated functions |
| EP2435049A1 (de) * | 2009-05-27 | 2012-04-04 | Sucampo AG | Pharmazeutische zusammensetzung mit prostaglandinderivaten für die modulation von claudinvermittelten funktionen und für die behandlung von hauterkrankungen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3632627A (en) * | 1968-01-05 | 1972-01-04 | Smith Kline French Lab | Glyceride derivatives of prostaglandins |
| US4054736A (en) * | 1970-06-10 | 1977-10-18 | Ono Pharmaceutical Co., Ltd. | Clathrate compounds of prostaglandins or their analogues with cyclodextrin |
-
1996
- 1996-08-20 KR KR1019960034329A patent/KR100227541B1/ko not_active Expired - Fee Related
- 1996-08-22 US US08/701,486 patent/US5698590A/en not_active Expired - Fee Related
- 1996-08-23 AT AT96306174T patent/ATE189214T1/de not_active IP Right Cessation
- 1996-08-23 EP EP96306174A patent/EP0760366B1/de not_active Expired - Lifetime
- 1996-08-23 DK DK96306174T patent/DK0760366T3/da active
- 1996-08-23 ES ES96306174T patent/ES2142547T3/es not_active Expired - Lifetime
- 1996-08-23 PT PT96306174T patent/PT760366E/pt unknown
- 1996-08-23 DE DE69606364T patent/DE69606364T2/de not_active Expired - Fee Related
-
2000
- 2000-04-12 GR GR20000400889T patent/GR3033195T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3033195T3 (en) | 2000-08-31 |
| DE69606364T2 (de) | 2000-06-08 |
| PT760366E (pt) | 2000-07-31 |
| US5698590A (en) | 1997-12-16 |
| KR970010743A (ko) | 1997-03-27 |
| EP0760366B1 (de) | 2000-01-26 |
| ES2142547T3 (es) | 2000-04-16 |
| ATE189214T1 (de) | 2000-02-15 |
| KR100227541B1 (ko) | 1999-11-01 |
| EP0760366A1 (de) | 1997-03-05 |
| DE69606364D1 (de) | 2000-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE237324T1 (de) | Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen | |
| FR2680366B1 (fr) | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| CA2259621A1 (en) | Isocoumarin derivatives and their use in medicines | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| DE68906609D1 (de) | Dopamin-vorlaeufer. | |
| TNSN87012A1 (fr) | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques | |
| ES2051479T3 (es) | Uso de imidazoles substituidos en 4 para disminuir la presion intraocular. | |
| KR890003382A (ko) | 항 비루스성 화합물 | |
| ATE185559T1 (de) | Prostaglandin-derivate | |
| ATE292117T1 (de) | Zusammensetzungen zur behandlung von hautkrankheiten | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| ATE189214T1 (de) | Prostaglandinderivate | |
| NO173991C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater | |
| FR2363324A1 (fr) | Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile | |
| TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
| ES2171749T3 (es) | Composiciones farmaceuticas que contienen inhibidores de la agregacion de plaquetas. | |
| ES2134441T3 (es) | Benzonitrilos terapeuticos. | |
| DE69330269D1 (de) | Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel | |
| DE3585070D1 (de) | Tetrahydro-1,2,4-oxadiazin-5-thion-derivate. | |
| ITMI913461A1 (it) | Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione | |
| ITMI930273A0 (it) | Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono |